Home / CRTX.L : LSE

AI Analysis Fundamentals Video Analysis Similar

AI Analysis

How does CRTX.L make money? Does CRTX.L have pricing power? What's the Earnings Whisper? Will CRTX.L profit more as the business scales? What is CRTX.L's management track record? Is CRTX.L's current price justified?

CRISM Therapeutics Corporation

10.66p +$0.66 (+6.56%)

LSE · 16 Sep 2026 09:14 UTC

Previous Close

11.25p

Day Range

10.5p12p

Year Range

8p18.5p

Market Cap

4.1M

AVG Volume

248.93K

Trailing/Forward PE

-2.06/-

PEG ratio

-0.05

Dividend Yield

Next Earnings Date

2026-09-23

Primary Exchange

London Stock Exchange

Net Income (GBP)

CRTX.L Net Income (GBP) by quarter
Period	Net Income (GBP)
25 Q4	-973K
25 Q2	-936.62K
24 Q4	-594K
24 Q2	-13K
23 Q4	-77.1K
23 Q2	-170.95K
22 Q4	-1.11M
22 Q2	-1.95M
21 Q4	-2.01M
21 Q2	234.81K

Operating Income (GBP)

CRTX.L Operating Income (GBP) by quarter
Period	Operating Income (GBP)
25 Q4	-1.2M
25 Q2	-914.47K
24 Q4	-605K
24 Q2	-300K
23 Q4	-292.54K
23 Q2	75.82K
22 Q4	-932.57K
22 Q2	-1.61M
21 Q4	-629.61K
21 Q2	-1.15M

EBITDA (GBP)

CRTX.L EBITDA (GBP) by quarter
Period	EBITDA (GBP)
25 Q4	-1.19M
25 Q2	-906.41K
24 Q4	-597K
24 Q2	4.83K
23 Q4	-54.35K
23 Q2	-140.56K
22 Q4	-932.57K
22 Q2	-1.61M
21 Q4	-629.6K
21 Q2	-1.15M

Cash Flows (GBP)

CRTX.L Cash Flows (GBP) by quarter
Period	Cash Flows (GBP)
25 Q4	-1.1M
25 Q2	-875.19K
24 Q4	-458K
24 Q2	-474.96K
23 Q4	6.32K
23 Q2	-2.19M
22 Q4	-2.19M
22 Q2	-1.65M
21 Q4	-803.31K
21 Q2	-1.14M

EPS (GBP)

CRTX.L EPS (GBP) by quarter
Period	EPS (GBP)
25 Q4	-0.02
25 Q2	-0.03
24 Q4	-0.02
24 Q2	-0
23 Q4	-0.01
23 Q2	-0.02
22 Q4	-0.12
22 Q2	-0.2
21 Q4	-0.27
21 Q2	0.03

Expenses (GBP)

CRTX.L Expenses (GBP) by quarter
Period	Expenses (GBP)
25 Q4	1.09M
25 Q2	911.45K
24 Q4	586K
24 Q2	381.97K
23 Q4	282.43K
23 Q2	2.03M
22 Q4	964.76K
22 Q2	2.02M
21 Q4	635.59K
21 Q2	1.58M

Cash & Debt (GBP)

CRTX.L Cash & Debt (GBP) by quarter
Period	Cash & Debt (GBP)
25 Q4	1.13M
25 Q2	351.49K
24 Q4	1.28M
24 Q2	1.86M
23 Q4	5.33M
23 Q2	7.1M
22 Q4	2.9M
22 Q2	5.3M
21 Q4	6.65M
21 Q2	1.85M

Debt ratios

CRTX.L Debt ratios by quarter
Period	Debt ratios
25 Q4	0.42
25 Q2	0.23
24 Q4	1.63
24 Q2	1.66
23 Q4	1.95
23 Q2	2
22 Q4	0.67
22 Q2	1.01
21 Q4	1.35
21 Q2	0.36

Return on Capital

CRTX.L Return on Capital by quarter
Period	Return on Capital
25 Q4	-68.71%
25 Q2	-70.99%
24 Q4	-40.27%
24 Q2	-0.63%
23 Q4	-1.87%
23 Q2	-4.78%
22 Q4	-4.81%
22 Q2	-5.28%
21 Q4	-6.69%
21 Q2	0.73%

Shares Outstanding

CRTX.L Shares Outstanding by quarter
Period	Shares Outstanding
25 Q4	41.01M
25 Q2	32.68M
24 Q4	32.68M
24 Q2	6.08M
23 Q4	8.71M
23 Q2	8.7M
22 Q4	8.71M
22 Q2	8.69M
21 Q4	8.62M
21 Q2	8.62M

Dividends (GBP)

CRTX.L Dividends (GBP) by quarter
Period	Dividends (GBP)
Jun 23	288

Book Value Per Share (GBP)

CRTX.L Book Value Per Share (GBP) by quarter
Period	Book Value Per Share (GBP)
25 Q4	0.03
25 Q2	0.04
24 Q4	0.05
24 Q2	0.34
23 Q4	0.47
23 Q2	0.41
22 Q4	2.66
22 Q2	4.25
21 Q4	3.48
21 Q2	3.72

Total Assets (GBP)

CRTX.L Total Assets (GBP) by quarter
Period	Total Assets (GBP)
25 Q4	1.8M
25 Q2	1.75M
24 Q4	1.82M
24 Q2	2.42M
23 Q4	4.79M
23 Q2	7.78M
22 Q4	23.89M
22 Q2	38.36M
21 Q4	31.11M
21 Q2	33.06M

No video analysis for this stock yet. Request one from our team.

AI Analysis

CRISM Therapeutics Corporation

Video analysis: CRTX.L

Similar companies